Related references
Note: Only part of the references are listed.International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab
Sandra Prior et al.
MABS (2018)
Maintaining consistent quality and clinical performance of biopharmaceuticals
William C. Lamanna et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)
Juyong Hong et al.
MABS (2017)
Establishment of the first WHO International Standard for etanercept, a TNF receptor II Fc fusion protein: Report of an international collaborative study
Meenu Wadhwa et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
Kristin K. Jorgensen et al.
LANCET (2017)
Glycosylation profile and biological activity of Remicade® compared with Flixabi® and Remsima®
Changsoo Lee et al.
MABS (2017)
Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar
Seokkyun Kim et al.
MABS (2017)
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma
Mar Riveiro-Barciela et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Monoclonal antibody biosimilars
Natasha Udpa et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
George D. Kalliolias et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Clinical Outcomes Following a Switch from RemicadeA® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study
Lisa J. T. Smits et al.
JOURNAL OF CROHNS & COLITIS (2016)
Human placenta: relative content of antibodies of different classes and subclasses (IgG1-IgG4) containing lambda- and kappa-light chains and chimeric lambda-kappa-immunoglobulins
Evgenii A. Lekchnov et al.
INTERNATIONAL IMMUNOLOGY (2015)
Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab)
Paul W. Tebbey et al.
MABS (2015)
Biologics in inflammatory bowel disease: what are the data?
Justin Cote-Daigneault et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2015)
Drift, Evolution, and Divergence in Biologics and Biosimilars Manufacturing
Sundar Ramanan et al.
BIODRUGS (2014)
Catching the Therapeutic Window of Opportunity in Early Crohn's Disease
Silvio Danese et al.
CURRENT DRUG TARGETS (2014)
Flexor tendon repair: a comparative study between a knotless barbed suture repair and a traditional four-strand monofilament suture repair
C. W. Joyce et al.
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME (2014)
Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies
Zhijie Jey Cheng et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Physicochemical characterization of Remsima®
Soon Kwan Jung et al.
MABS (2014)
Biosimilars in rheumatology: the wind of change
Christian K. Schneider
ANNALS OF THE RHEUMATIC DISEASES (2013)
The State of the Art in the Development of Biosimilars
Mark McCamish et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Intended use of Reference Products & WHO International Standards/Reference Reagents in the development of Similar Biological Products (Biosimilars)
Robin Thorpe et al.
BIOLOGICALS (2011)
The value of early intervention in RA-a window of opportunity
Ferdinand Breedveld
CLINICAL RHEUMATOLOGY (2011)
Establishment of gerbil-mouse heterohybridoma secreting immunoglobulin of Mongolian gerbil (Meriones unguiculatus) Establishment of gerbil-mouse heterohybridoma
Takao Ukaji et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Proteomic differentiation pattern in the U937 cell line
Luigi Minafra et al.
LEUKEMIA RESEARCH (2011)
Interaction databases on the same page
Andrei L. Turinsky et al.
NATURE BIOTECHNOLOGY (2011)
Remission and rheumatoid arthritis - Data on patients receiving usual care in twenty-four countries
Tuulikki Sokka et al.
ARTHRITIS AND RHEUMATISM (2008)
Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker
S. Danese
DIGESTIVE AND LIVER DISEASE (2008)
Share Paper
